I don't know of anyone. It just started Phase I clinical trial in May 2008, so not much data available. But AP24534 is a kinase inhibitor that apparently works against the difficult T315i mutant that none of the existing CML drugs work against. So that makes this an important clinical trial. Are you planning to enroll in the clinical trial, and do you have the T315i mutation?
http://www.medicalnewstoday.com/articles/126927.php Here is what Ariad says about their drug: http://www.ariad.com/wt/tertiarypage/kinase_inhibitors --~--~---------~--~----~------------~-------~--~----~ [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/CMLHope -~----------~----~----~----~------~----~------~--~---
